Belimumab After Rituximab in Resistant Primary Juvenile SS | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Belimumab After Rituximab in Resistant Primary Juvenile SS	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, childhood acute lymphoblastic leukemia, connective tissue disorder, dry eye syndrome, eye disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, lacrimal apparatus disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mouth disorder, musculoskeletal system disorder, neoplasm, rheumatic disorder, rheumatoid arthritis, salivary gland disorder	Recruiting	Phase 4	2024-05-16		NCT06410833

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Central South University	36
Children's Hospital of Chongqing Medical University	24
Children's Hospital of Fudan University	104
Children's Hospital of Nanjing Medical University	7
Children's Hospital of The Capital Institute of Pediatrics	6
Peking Union Medical College Hospital	417
Shanghai Children's Hospital	15
Shengjing Hospital	111
Shenzhen Children's Hospital	16
The Affiliated Hospital of Qingdao University	124
The First Hospital of Jilin University	154
Tianjin Children's Hospital	8

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking Union Medical College Hospital	Beijing	China	201